Works about MEFLOQUINE


Results: 390
    1
    2
    3
    4

    Resistance to Antimalarial Monotherapy Is Cyclic.

    Published in:
    Journal of Clinical Medicine, 2022, v. 11, n. 3, p. 781, doi. 10.3390/jcm11030781
    By:
    • Weitzman, Rachel;
    • Calfon-Peretz, Ortal;
    • Saha, Trishna;
    • Bloch, Naamah;
    • Ben Zaken, Karin;
    • Rosenfeld, Avi;
    • Amitay, Moshe;
    • Samson, Abraham O.
    Publication type:
    Article
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17

    Unlike Chloroquine, Mefloquine Inhibits SARS-CoV-2 Infection in Physiologically Relevant Cells.

    Published in:
    Viruses (1999-4915), 2022, v. 14, n. 2, p. 374, doi. 10.3390/v14020374
    By:
    • Sacramento, Carolina Q.;
    • Fintelman-Rodrigues, Natalia;
    • Dias, Suelen S. G.;
    • Temerozo, Jairo R.;
    • Da Silva, Aline de Paula D.;
    • da Silva, Carine S.;
    • Blanco, Camilla;
    • Ferreira, André C.;
    • Mattos, Mayara;
    • Soares, Vinicius C.;
    • Pereira-Dutra, Filipe;
    • Miranda, Milene Dias;
    • Barreto-Vieira, Debora F.;
    • da Silva, Marcos Alexandre N.;
    • Santos, Suzana S.;
    • Torres, Mateo;
    • Chaves, Otávio Augusto;
    • Rajoli, Rajith K. R.;
    • Paccanaro, Alberto;
    • Owen, Andrew
    Publication type:
    Article
    18
    19
    20
    21
    22
    23
    25
    26
    29
    30
    31
    32

    Randomized Comparison of Chloroquine plus Sulfadoxine-Pyrimethamine versus Artesunate plus Mefloquine versus Artemether-Lumefantrine in the Treatment of Uncomplicated Falciparum Malaria in the Lao People's Democratic Republic.

    Published in:
    Clinical Infectious Diseases, 2004, v. 39, n. 8, p. 1139, doi. 10.1086/424512
    By:
    • Mayxay, Mayfong;
    • Khanthavong, Maniphone;
    • Lindegårdh, Niklas;
    • Keola, Siamphay;
    • Barends, Marion;
    • Pongvongsa, Tiengkham;
    • Yapom, Ratsuda;
    • Annerberg, Anna;
    • Phompida, Samlane;
    • Phetsouvanh, Rattanaxay;
    • White, Nicholas J.;
    • Newton, Paul N.
    Publication type:
    Article
    33
    34
    35
    36

    Prioritization of Anti‐SARS‐Cov‐2 Drug Repurposing Opportunities Based on Plasma and Target Site Concentrations Derived from their Established Human Pharmacokinetics.

    Published in:
    Clinical Pharmacology & Therapeutics, 2020, v. 108, n. 4, p. 775, doi. 10.1002/cpt.1909
    By:
    • Arshad, Usman;
    • Pertinez, Henry;
    • Box, Helen;
    • Tatham, Lee;
    • Rajoli, Rajith K. R.;
    • Curley, Paul;
    • Neary, Megan;
    • Sharp, Joanne;
    • Liptrott, Neill J.;
    • Valentijn, Anthony;
    • David, Christopher;
    • Rannard, Steve P.;
    • O'Neill, Paul M.;
    • Aljayyoussi, Ghaith;
    • Pennington, Shaun H.;
    • Ward, Stephen A.;
    • Hill, Andrew;
    • Back, David J.;
    • Khoo, Saye H.;
    • Bray, Patrick G.
    Publication type:
    Article
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50